[Bacterial enteric pathogens' resistance to fluoroquinolones and last generation cephalosporines]

Maria Damian1, Codruţa-Romanita Usein, Andi Marian Palade

  • 1Institutul Naţional de Cercetare-Dezvoltare pentru Microbiologie şi Imunologie Cantacuzino, Bucureşti.

Bacteriologia, Virusologia, Parazitologia, Epidemiologia (Bucharest, Romania : 1990)
|May 11, 2011
PubMed

Insights

Antibiotic resistance in enteric bacteria is rising due to genetic mutations and mobile gene transfer. This study examines extended-spectrum beta-lactamases (ESBLs) and fluoroquinolone resistance, posing a significant public health threat.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Antibiotic resistance is a growing global health concern.
  • The bacterial resistome encompasses genetic mechanisms of antibiotic defense.
  • Rising resistance in enteric bacteria to advanced antibiotics like cephalosporins and fluoroquinolones is critical.

Purpose of the Study:

  • To investigate the mechanisms of antibiotic resistance in enteric bacteria.
  • To analyze the role of extended-spectrum beta-lactamases (ESBLs) and fluoroquinolone resistance genes.
  • To highlight the public health implications of antibiotic resistance spread.

Main Methods:

  • Analysis of genetic mutations in bla genes responsible for beta-lactamase synthesis.
  • Identification of punctual mutations in gyr genes conferring fluoroquinolone resistance.
  • Review of known ESBL types (TEM, SHV, CTX-M) and their prevalence.

Main Results:

  • Enteric bacteria produce diverse ESBLs (TEM, SHV, CTX-M) through genetic mutations.
  • Escherichia coli and Klebsiella pneumoniae strains exhibit resistance to cephalosporins and fluoroquinolones.
  • Fluoroquinolone resistance genes (qnr) on mobile structures exacerbate the threat.

Conclusions:

  • ESBL production and fluoroquinolone resistance in enteric bacteria are significant threats.
  • Mobile genetic elements facilitate the rapid spread of antibiotic resistance genes.
  • Urgent public health strategies are needed to combat escalating antibiotic resistance.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...